ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Amgen Inc

Amgen Inc (1AMGN)

256.50
-0.75
(-0.29%)
Closed January 12 11:30AM

Amgen Inc Financial Summary

The current 1AMGN market cap is 137.88B. The company's latest EPS is USD 12.4960 and P/E is 20.99.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 23.36B25.42B25.98B26.32B28.19B
Operating Income 9.67B9.14B7.64B9.67B9.38B
Net Income 7.84B7.26B5.89B6.55B6.72B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 59.71B62.95B61.17B65.12B97.15B
Total Liabilities 50.03B53.54B54.47B61.46B90.92B
Total Equity 9.67B9.41B6.7B3.66B6.23B

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 9.15B10.5B9.26B9.72B8.47B
Investing 5.71B-5.4B733M-6.04B-26.2B
Financing -15.77B-4.87B-8.27B-4.04B21.05B
Market Cap 137.88B
Price to Earnings Ratio 20.99
Price to Sales Ratio 5
Price to Cash Ratio 12.88
Price to Book Ratio 22.62
Dividend Yield 3.80%

Share Statistics

Shares Outstanding 537.53M
Average Volume (1 week) 40
Average Volume (1 Month) 100
52 Week Change -6.93%
52 Week High 337.65
52 Week Low 244.55
Spread (Intraday) 0.85 (0.33%)

Company Info

Company Name Amgen Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.amgen.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock